{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:24:26Z","timestamp":1761675866665,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ajog.2011.06.048","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T20:27:21Z","timestamp":1309033641000},"page":"460.e1-460.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States"],"prefix":"10.1016","volume":"205","author":[{"given":"Thomas N.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond A.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Colligs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean D.","family":"Candrilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2011.06.048_bib1","doi-asserted-by":"crossref","first-page":"285S","DOI":"10.1093\/ajcn\/85.1.285S","article-title":"Folate and neural tube defects","volume":"85","author":"Pitkin","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajog.2011.06.048_bib2","first-page":"1","article-title":"Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis: United States, 1985-1994","volume":"44","author":"Cragan","year":"1995","journal-title":"MMWR CDC Surveill Summ"},{"key":"10.1016\/j.ajog.2011.06.048_bib3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199911113412006","article-title":"Neural-tube defects","volume":"341","author":"Botto","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2011.06.048_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/bdra.20360","article-title":"Health care expenditures of children and adults with spina bifida in a privately insured US population","volume":"79","author":"Ouyang","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"RR-14","key":"10.1016\/j.ajog.2011.06.048_bib5","article-title":"Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects","volume":"41","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2011.06.048_bib6","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1995.03530210052030","article-title":"Folate levels and neural tube defects","volume":"274","author":"Daly","year":"1995","journal-title":"JAMA"},{"year":"2009","series-title":"Preventing neural tube birth defects: a prevention model and resource guide","author":"Burke","key":"10.1016\/j.ajog.2011.06.048_bib7"},{"key":"10.1016\/j.ajog.2011.06.048_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/0003-4819-150-9-200905050-00009","article-title":"Folic acid for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2011.06.048_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/ajcn\/85.5.1409","article-title":"Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002","volume":"85","author":"Yang","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajog.2011.06.048_bib10","first-page":"5","article-title":"Use of supplements containing folic acid among women of childbearing age\u2014United States, 2007","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2011.06.048_bib11","first-page":"362","article-title":"Spina bifida and anencephaly before and after folic acid mandate\u2014United States, 1995-1996 and 1999-2000","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2011.06.048_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.ajog.2011.06.048_bib13","first-page":"1","article-title":"Fertility, family planning, and reproductive health of US women: data from the 2002 National Survey of Family Growth","volume":"23","author":"Chandra","year":"2005","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.ajog.2011.06.048_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/AOG.0b013e3181b46f54","article-title":"Rate of pregnancy following use of drospirenone- and other progestin-containing oral contraceptives","volume":"114","author":"Cronin","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.048_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/2991522","article-title":"Unintended pregnancy in the United States","volume":"30","author":"Henshaw","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.ajog.2011.06.048_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.06.048_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2307\/2991641","article-title":"Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth","volume":"31","author":"Trussell","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.ajog.2011.06.048_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1552-6356.2004.tb00149.x","article-title":"Fortifying oral contraceptives with folic acid","volume":"8","author":"Raven","year":"2004","journal-title":"AWHONN Lifelines"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2011.06.048_bib20","first-page":"158","article-title":"Changes in folate levels following a 24-week co-administration of Yasmin and levomefolate calcium 0.451 mg or folic acid 400 mcg","volume":"15","author":"Diefenbach","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2011.06.048_bib21","first-page":"157","article-title":"Changes in folate levels following cessation of Yasmin and levomefolate calcium 0.451 mg or folic acid 400 mcg co-administration","volume":"15","author":"Diefenbach","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2011.06.048_bib22","first-page":"159","article-title":"Folate and homocysteine levels after 24 weeks administration of YAZ + levomefolate calcium 0.451 mg","volume":"15","author":"Marr","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2011.06.048_bib24","first-page":"1","article-title":"Blood folate levels: the latest NHANES results","author":"McDowell","year":"2008","journal-title":"NCHS Data Brief"},{"year":"2004","series-title":"Use of contraception and use of family planning services in the United States, 1982-2002","author":"Mosher","key":"10.1016\/j.ajog.2011.06.048_bib25"},{"key":"10.1016\/j.ajog.2011.06.048_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0010-7824(99)00027-X","article-title":"Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand","volume":"59","author":"Colli","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.06.048_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.06.048_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2006.078451","article-title":"Comparison of serum folate species analyzed by LCMS\/MS with total folate measured by microbiologic assay and bio-rad radioassay","volume":"53","author":"Fazili","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2011.06.048_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/4000608","article-title":"Abortion in the United States: incidence and access to services, 2005","volume":"40","author":"Jones","year":"2008","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.ajog.2011.06.048_bib32","first-page":"1","article-title":"Medical and life-style risk factors affecting fetal mortality, 1989-90","volume":"20","author":"Hoyert","year":"1996","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.ajog.2011.06.048_bib33","first-page":"937","article-title":"Modelling the potential impact of population-wide periconceptional folate\/multivitamin supplementation on multiple births","volume":"108","author":"Lumley","year":"2001","journal-title":"BJOG"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811007769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811007769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:43:46Z","timestamp":1757587426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937811007769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0002937811007769"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2011.06.048","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2011.06.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}